Ekso Bionics Holdings Inc (EKSO)

$0.42 +0.01 (2.32%)
Market Cap 10.07M
Revenue (ttm) 17.93M
Net Income (ttm) -11.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -63.19%
Debt to Equity Ratio 0.30
Volume 89,400
Avg Vol 260,450
Day's Range N/A - N/A
Shares Out 24.83M
Stochastic %K 16%
Beta 1.33
Analysts Strong Sell
Price Target $5.00

Latest News on EKSO

Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 9:44 PM EST - 4 weeks ago

Ekso Bionics Holdings, Inc. (EKSO) Q4 2024 Earnings Call Transcript

Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results

Mar 3, 2025, 4:05 PM EST - 4 weeks ago

Ekso Bionics Reports Fourth Quarter and Full-Year 2024 Financial Results

Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow

Feb 24, 2025, 4:30 PM EST - 5 weeks ago

Ekso Bionics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3 – Conference Call to Follow

NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry

Feb 10, 2025, 7:00 AM EST - 7 weeks ago

NSM Named Exclusive Distributor of Ekso Indego® Personal Within the CRT Industry

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19

Nov 18, 2024, 8:04 AM EST - 4 months ago

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference

Nov 12, 2024, 8:00 AM EST - 5 months ago

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript

Oct 28, 2024, 5:55 PM EDT - 5 months ago

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript

Ekso Bionics Announces Third Quarter 2024 Financial Results

Oct 28, 2024, 4:05 PM EDT - 5 months ago

Ekso Bionics Announces Third Quarter 2024 Financial Results

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024

Oct 21, 2024, 8:00 AM EDT - 5 months ago

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering

Aug 29, 2024, 10:42 PM EDT - 7 months ago

Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering

Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript

Jul 29, 2024, 10:10 PM EDT - 8 months ago

Ekso Bionics Holdings, Inc. (EKSO) Q2 2024 Earnings Call Transcript

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024

Jul 29, 2024, 4:05 PM EDT - 8 months ago

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024

Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024

Jul 22, 2024, 8:00 AM EDT - 9 months ago

Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024

Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors

Jun 17, 2024, 4:05 PM EDT - 10 months ago

Ekso Bionics Appoints Deborah Lafer Scher to its Board of Directors

Artificial Intelligence in the Global Prosthetic Market 2024-2033, with Profiles of Ossur, Blatchford, Ottobock, Ekso Bionics, Open Bionics, Advanced Arm Dynamics and BrainRobotics

Jun 7, 2024, 4:31 AM EDT - 10 months ago

Artificial Intelligence in the Global Prosthetic Market 2024-2033, with Profiles of Ossur, Blatchford, Ottobock, Ekso Bionics, Open Bionics, Advanced Arm Dynamics and BrainRobotics

Ekso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew Pinsky

May 10, 2024, 8:00 AM EDT - 11 months ago

Ekso Indego Personal to be Featured on ‘Health Uncensored' with Dr. Drew Pinsky

Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript

Apr 29, 2024, 7:39 PM EDT - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) Q1 2024 Earnings Call Transcript

Ekso Bionics Announces First Quarter 2024 Financial Results

Apr 29, 2024, 4:05 PM EDT - 1 year ago

Ekso Bionics Announces First Quarter 2024 Financial Results

Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024

Apr 22, 2024, 8:00 AM EDT - 1 year ago

Ekso Bionics to Report First Quarter 2024 Financial Results on April 29, 2024

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

Apr 12, 2024, 8:00 AM EDT - 1 year ago

Ekso Bionics Receives Final Payment Determination for Medicare Reimbursement from the Centers for Medicare & Medicaid Services (CMS) for Ekso Indego Personal

Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 8:07 PM EST - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) Q4 2023 Earnings Call Transcript

Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Mar 4, 2024, 4:05 PM EST - 1 year ago

Ekso Bionics Reports Record Annual Revenue of $18.3 Million

Ekso Bionics Launches GaitCoach Software for EksoNR

Jan 8, 2024, 4:05 PM EST - 1 year ago

Ekso Bionics Launches GaitCoach Software for EksoNR

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

Jan 4, 2024, 5:05 PM EST - 1 year ago

Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

Nov 16, 2023, 4:05 PM EST - 1 year ago

Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29

Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal

Nov 2, 2023, 4:01 PM EDT - 1 year ago

Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal

Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call Transcript

Oct 26, 2023, 6:23 PM EDT - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) Q3 2023 Earnings Call Transcript

Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Oct 26, 2023, 4:05 PM EDT - 1 year ago

Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38%

Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023

Oct 19, 2023, 4:05 PM EDT - 1 year ago

Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023

Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 11, 2023, 8:00 AM EDT - 1 year ago

Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference

Ekso Bionics Holdings, Inc. (EKSO) Q2 2023 Earnings Call Transcript

Jul 27, 2023, 8:24 PM EDT - 1 year ago

Ekso Bionics Holdings, Inc. (EKSO) Q2 2023 Earnings Call Transcript

Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023

Jul 20, 2023, 8:00 AM EDT - 1 year ago

Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023

Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript

Apr 27, 2023, 10:09 PM EDT - 2 years ago

Ekso Bionics Holdings, Inc. (EKSO) Q1 2023 Earnings Call Transcript

Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues

Apr 27, 2023, 4:05 PM EDT - 2 years ago

Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues

Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023

Apr 20, 2023, 8:00 AM EDT - 2 years ago

Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023

Ekso Bionics Announces Ekso Indego Therapy Order by SoldierStrong

Apr 17, 2023, 4:05 PM EDT - 2 years ago

Ekso Bionics Announces Ekso Indego Therapy Order by SoldierStrong

Ekso Bionics Holdings, Inc. (EKSO) Q4 2022 Earnings Call Transcript

Mar 28, 2023, 6:08 PM EDT - 2 years ago

Ekso Bionics Holdings, Inc. (EKSO) Q4 2022 Earnings Call Transcript

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

Mar 28, 2023, 4:26 PM EDT - 2 years ago

Ekso Bionics Reports Fourth Quarter and Year End 2022 Results

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

Feb 23, 2023, 8:00 AM EST - 2 years ago

Ekso Bionics to Showcase Integrated Functional Electrical Stimulation for Indego Therapy at APTA Meeting

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

Dec 5, 2022, 8:37 AM EST - 2 years ago

Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego® Product Line From Parker Hannifin Corporation

Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Call Transcript

Nov 6, 2022, 11:25 AM EST - 2 years ago

Ekso Bionics Holdings, Inc. (EKSO) Q3 2022 Earnings Call Transcript

Ekso Bionics Reports Third Quarter 2022 Results

Nov 3, 2022, 4:05 PM EDT - 2 years ago

Ekso Bionics Reports Third Quarter 2022 Results

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

Sep 6, 2022, 4:05 PM EDT - 2 years ago

Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference

Ekso Bionics: Fragile Opportunity

Aug 24, 2022, 4:34 AM EDT - 2 years ago

Ekso Bionics: Fragile Opportunity

Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call Transcript

Jul 28, 2022, 7:53 PM EDT - 2 years ago

Ekso Bionics Holdings, Inc. (EKSO) CEO Steven Sherman on Q2 2022 Results - Earnings Call Transcript

Ekso Bionics Reports Second Quarter 2022 Results

Jul 28, 2022, 4:05 PM EDT - 2 years ago

Ekso Bionics Reports Second Quarter 2022 Results

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

Jul 21, 2022, 8:00 AM EDT - 2 years ago

Ekso Bionics to Report Second Quarter 2022 Financial Results on July 28

Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

Jun 13, 2022, 8:00 AM EDT - 3 years ago

Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Multiple Sclerosis Patients

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

May 26, 2022, 7:00 AM EDT - 3 years ago

Ekso Bionics Appoints Jerome Wong Interim Chief Financial Officer

Ekso Bionics Reports First Quarter 2022 Results

Apr 28, 2022, 4:05 PM EDT - 3 years ago

Ekso Bionics Reports First Quarter 2022 Results